Available Clinical Trials

Available Clinical Trials 

  • A Randomized Study Evaluating Patients Discharged with Indwelling Chest Tube and Valve

    PI: K. Robert Shen, MD, Mayo Clinic Rochester

    Phase

    Phase II

    Methodology

    Randomized

    Overall Study Duration

    5 years

    Subject Participation Duration

    30 Days

    Objectives

    Primary Objective

    To assess the efficacy of antibiotics and closer monitoring on decreasing empyema in patients discharging with a chest tube and valve in place as measured by documented empyema following discharge.

    Secondary Objective

    To assess the efficacy of antibiotics and closer monitoring on decreasing hospital readmissions while the chest tube and valve are in place as measured by readmission to the hospital following hospital discharge after the initial surgical intervention.

    Number of Subjects

    560

    Diagnosis and Main Inclusion Criteria

    Discharge from the hospital with an indwelling chest tube and valve in place

    Study Treatment

    Oral antibiotics and close monitoring (defined as twice weekly telephone calls by a member of the care team)

    Reference Treatment

    Standard of Care (defined as no calls from the care team but waiting for the subject to contact the care team when the air leak has stopped)

    Statistical Methodology

    Comparison of the rate of empyema and readmission in the two arms of the study

     

  • Protocal
  • Consent 
  • Schema 
  • Contact for more Information
image widget
JOIN DONATE SEARCH
Facebook Twitter